Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20522307rdf:typepubmed:Citationlld:pubmed
pubmed-article:20522307lifeskim:mentionsumls-concept:C0005684lld:lifeskim
pubmed-article:20522307lifeskim:mentionsumls-concept:C0034897lld:lifeskim
pubmed-article:20522307lifeskim:mentionsumls-concept:C0441712lld:lifeskim
pubmed-article:20522307pubmed:issue6lld:pubmed
pubmed-article:20522307pubmed:dateCreated2010-9-7lld:pubmed
pubmed-article:20522307pubmed:abstractTextBladder cancer recurrence occurs via four mechanisms - incomplete resection, tumour cell re-implantation, growth of microscopic tumours, and new tumour formation. The first two mechanisms are influenced by clinicians before and immediately after resection; the remaining mechanisms have the potential to be influenced by chemopreventive agents. However, the relative importance and timing of these mechanisms is currently unknown. Our objective was to postulate the incidence and timing of these mechanisms by investigating the location of bladder cancer recurrences over time.lld:pubmed
pubmed-article:20522307pubmed:languageenglld:pubmed
pubmed-article:20522307pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20522307pubmed:citationSubsetIMlld:pubmed
pubmed-article:20522307pubmed:statusMEDLINElld:pubmed
pubmed-article:20522307pubmed:monthSeplld:pubmed
pubmed-article:20522307pubmed:issn1478-7083lld:pubmed
pubmed-article:20522307pubmed:authorpubmed-author:ChengK KKKlld:pubmed
pubmed-article:20522307pubmed:authorpubmed-author:CollinsStuart...lld:pubmed
pubmed-article:20522307pubmed:authorpubmed-author:WallaceD...lld:pubmed
pubmed-article:20522307pubmed:authorpubmed-author:BryanRichard...lld:pubmed
pubmed-article:20522307pubmed:authorpubmed-author:ZeegersMauric...lld:pubmed
pubmed-article:20522307pubmed:authorpubmed-author:DaykinMark...lld:pubmed
pubmed-article:20522307pubmed:authorpubmed-author:SoleGraham...lld:pubmed
pubmed-article:20522307pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20522307pubmed:volume92lld:pubmed
pubmed-article:20522307pubmed:ownerNLMlld:pubmed
pubmed-article:20522307pubmed:authorsCompleteYlld:pubmed
pubmed-article:20522307pubmed:pagination519-24lld:pubmed
pubmed-article:20522307pubmed:dateRevised2011-11-14lld:pubmed
pubmed-article:20522307pubmed:meshHeadingpubmed-meshheading:20522307...lld:pubmed
pubmed-article:20522307pubmed:meshHeadingpubmed-meshheading:20522307...lld:pubmed
pubmed-article:20522307pubmed:meshHeadingpubmed-meshheading:20522307...lld:pubmed
pubmed-article:20522307pubmed:meshHeadingpubmed-meshheading:20522307...lld:pubmed
pubmed-article:20522307pubmed:meshHeadingpubmed-meshheading:20522307...lld:pubmed
pubmed-article:20522307pubmed:meshHeadingpubmed-meshheading:20522307...lld:pubmed
pubmed-article:20522307pubmed:year2010lld:pubmed
pubmed-article:20522307pubmed:articleTitleMechanisms of recurrence of Ta/T1 bladder cancer.lld:pubmed
pubmed-article:20522307pubmed:affiliationDepartment of Public Health, Epidemiology and Biostatistics, School of Population Sciences, University of Birmingham, Birmingham, UK. r.t.bryan@bham.ac.uklld:pubmed
pubmed-article:20522307pubmed:publicationTypeJournal Articlelld:pubmed